Researchers uncover corneal changes in multiple myeloma patients treated with belantamab mafodotin, revealing potential ...

A new commentary published in Annals of Internal Medicine from Roy Gulick, MD, Chief, Division of Infectious Diseases and ...

Some people may be more vulnerable to infections and illnesses than others and several factors can be to blame Here’s what a ...

FREDERICK, Md., May 08, 2025 (GLOBE NEWSWIRE) -- Cartesian Therapeutics, Inc. (NASDAQ: RNAC) (the "Company”), a clinical-stage biotechnology company pioneering cell therapy for autoimmune diseases, ...

The multiple myeloma armamentarium is large and getting larger. That makes treatment choices complex and the cost of ...

Phase 2 ARCHER Data Support Therapeutic Potential for ANX007 to Preserve Vision in Patients who have Dry Age-related Macular Degeneration (AMD) with Geographic Atrophy (GA) Phase 3 ARCHER II Trial ...

Health experts raise concerns about the rise in vaccine skepticism and hesitancy as a bill criminalizing certain vaccines ...

IDEAYA Biosciences, Inc. (NASDAQ: IDYA), a precision medicine oncology company committed to the discovery and development of targeted therapeutics, announced the clearance of an investigational new ...

Q1 2025 Earnings Conference Call May 9, 2025 10:00 AM ETCompany ParticipantsJustine Koenigsberg - Vice President ...

Detailed Analysis Into the Regulatory Landscape, Patent Landscape, Key Trends, Clinical Trails, Pricing Analysis, Market Dynamics and MoreDublin, May 06, 2025 (GLOBE NEWSWIRE) -- The "Adult T-Cell ...

Q1 2025 Earnings Conference Call May 8, 2025 8:30 AM ETCompany ParticipantsLuis Sanay - Vice President, Investor ...

A new study published in the journal Alzheimer’s & Dementia reports that a novel vaccine targeting a toxic form of the tau ...